In vitro techniques for the assessment of neurotoxicity

Environmental Health Perspectives

Volumn 106, Issue SUPPL. 1, 1998, Pages 131-158

  Harry, G Jean ^a   Billingsley, Melvin ^b   Bruinink, Arend ^c   Campbell, Iain L ^d   Classen, Werner ^e   Dorman, David C ^f   Galli, Corrado ^g   Ray, David ^h   Smith, Robert A ⁱ   Tilson, Hugh A ^j  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF ZURICH   (Switzerland)

^d SCRIPPS RESEARCH INSTITUTE   (United States)

^e CIBA GEIGY LTD   (Switzerland)

^f CIIT CENTERS FOR HEALTH RESEARCH   (United States)

^g UNIVERSITY OF MILAN   (Italy)

^h UNIVERSITY OF LEICESTER   (United Kingdom)

ⁱ UNIVERSITY OF GLASGOW   (United Kingdom)

^j U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

more..

Author keywords

Astrocyte; Astrocytomas; Axonal transport; Blood brain barrier; Calcium; Cell lines; Central nervous system; Cytotoxicity; Glia; Glioma cell line; Glutamate; Myelin; Neuroblastoma cell line; Neuron; Neuropathy target esterase; Neurotransmitter; Oligodendroglia; Organ culture; Organophosphate; PC 12 cells; Peripheral nervous system; Primary cell cultures; Reaggregate cell culture; Tissue slice

Indexed keywords

ORGANOPHOSPHATE;

DOSE RESPONSE; DRUG TOXICITY; IN VITRO STUDY; IN VIVO STUDY; NEUROTOXICITY; PHARMACOLOGY; PREDICTION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT;

EID: 18744430350     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.98106s1131     Document Type: Review

References (212)

1. U.S. Environmental Protection Agency. Final Report. Principles of Neurotoxicity Risk Assessment [Notice]. Fed Reg 59:42360-42404 (1994).
2. National Academy of Sciences. Risk Assessment in the Federal Government: Managing the Process. Washington:National Academy Press, 1983.
3. National Research Council. Science and Judgment in Risk Assessment. National Research Council, Washington:National Academy Press, 1994.
4. Arenander AT, de Vellis J. Frontiers of glial physiology. In: The Clinical Neurosciences (Rosenberg R, ed). New York:Churchill Livingstone, 1983;53-91.
5. Fedoroff S, Vernadakis A. Astrocytes. Vol 2. Orlando, FL:Academic Press, 1987.
6. Saneto RP, de Vellis J. Neuronal and glial cells: cell culture of the central nervous system. In: Neurochemistry - A Practical Approach (Turner AJ, Bachelard HS, eds). Washington:IRL Press, 1987:27-63.
7. Shahar A, de Vellis J, Vernadakis A, Haber B. A Dissection and Tissue Culture Manual of the Nervous System. New York:Alan R. Liss, 1989.
8. Jacobson M. Developmental Neurobiology. New York: Plenum Press, 1991.
9. Fedoroff S. In vitro systems in medical research. In: The Future of Animals, Cells, Models, and Systems in Research, Development, Education, and Testing. Washington:National Academy of Sciences, 1977.
10. Juurlink BH, Hertz L. Plasticity of astrocytes in primary cultures: an experimental tool and a reason for methological caution. Dev Neurosci 7:263-277 (1985).
11. U.S. Environmental Protection Agency. Proposed Guidelines for Neurotoxicity Risk Assessment [Notice]. Fed Reg 60: 52032-52056 (1995).
12. Nardone RM. Toxicity testing in vitro. In: Growth, Nutrition, and Metabolism of Cells in Culture, Vol III (Rothblatt GH, Cristofalo VJ, eds). New York:Academic Press, 1977;471-495.
13. Rees KR. Cells in culture in toxicity testing: a review, J R Soc Med 73:261-264 (1980).
14. Schrier BK. Nervous system cultures as toxicologic test systems. In: Target Organ Toxicology Series: Nervous System Toxicology (Mitchell CL, ed). New York:Raven Press, 1982;337-348.
15. Balls M, Clothier R. Differentiated cell and organ culture in toxicity testing. Acta Pharm Toxicol 52(Suppl II):115-137 (1983).
16. Grisham JW, Smith GJ. Predictive and mechanistic evaluation of toxic responses in mammalian cell culture systems. Pharmacol Rev 36:151s-171s (1984).
17. Purchase IFH, Conning DM. International Conference on Practical in Vitro Toxicology. Food Chem Toxicol 24:447-818 (1986).
18. Moriuchi S, Shimizu K, Miyao Y, Yamada M, Ohkawa M, Hayakawa T. In vitro assessment for neurotoxicity of antitumor agents before local administration into central nervous system. Anticancer Res 16:135-140 (1996).
19. Vickers PJ, O'Neill GP, Mancini JA, Charleson S, Abramovitz M, Cross-species comparison of 5-lipoxygenase-activating protein. Mol Pharmacol 42:1014-1019 (1992).
20. Lowndes HE, Beiswanger CM, Philbert MA, Reuhl KR. Substrates for neural metabolism of xenobiotics in adult and developing brain. Neurotoxicology 15:61-73 (1994).
21. Kohn J, Durham HD. S9 liver fraction is cytotoxic to neurons in dissociated cultures. Neurotoxicology 14:381-386 (1993).
22. Ransom BR, Kunis DM, Irwin I, Langsten JW. Astrocytes convert the Parkinsonism inducing neurotoxin, MPTP, to its active metabolite MPPT. Neurosci Lett 75:323-328 (1987).
23. Hamberger A, Nystrom B, Sellstrom A, Woiler CT. Amino acid transport in isolated neurons and glia. Adv Exp Med Biol 69:221-236 (1976).
24. Holtzman D, DeVries C, Nguyen H, Olson J, Bensch K. Maturation of resistance to lead encephalopathy: cellular and subcellular mechanisms. Neurotoxicology 5:97-124 (1984).
25. Bruinink A. Serum-free monolayer cultures of embryonic chick brain and retina: immunoassays of developmental markers, mathematical data analysis and establishment of optimal culture conditions. In: The Brain in Bits and Pieces (Zbinden G, ed). Verlag Zolikon, 1992;23-50.
26. Betz AL, Goldstein GW, Katzman R. Blood-brain-cerebrospinal fluid barriers. In: Basic Neurochemistry, 5th ed (Siegel GJ, Agranoff BW, Albers RW, Molinoff PB, eds). New York:Raven Press, 1994;681-701.
27. Ronnetr GV, Hester LD, Nye JS, Connors K, Snyder SH. Human cortical neuronal cell line: establishment from a patient with unilateral megalencephaly. Science 248:603-605 (1990).
28. Stewart RM, Rosenberg RN. Physiology of glia: glial-neuronal interactions. Int Rev Neurobiol 21:275-309 (1979).
29. Hatten ME. Neuronal regulation of astroglial proliferation and differentiation. In: The Assembly of the Nervous System. New York:Alan R.Liss, 1989; 151-166.
30. Hatten ME. Neuronal regulation of astroglia morphology and proliferation in vitro. J Cell Biol 100:384-396 (1985).
31. Hatten ME. Neuronal regulation of astroglial proliferation is membrane-mediated. J Cell Biol 104:1353-1360 (1987).
32. Bruinink A, Reiser P, Muller M, Gahwiler BH, Zbinden G. Neurotoxic effects of bismuth in vitro. Toxicol In Vitro 6:285-293 (1992).
33. Hatten ME, Shelanski ML. Mouse cerebellar granule neurons arrest the proliferation of human and rodent astrocytoma cells in vitro. J Neurosci 8:1447-1453 (1988).
34. Laterra J, Bressler JP, Indurti RR, Belloni-Olivi L, Goldstein GW. Inhibition of astroglia-induced endothelial differentiation by inorganic lead: a role for protein kinase C. Proc Natl Acad Sci USA 89:10748-10752 (1992).
35. Richter-Landsberg, Besser A. Effects of organotins on rat brain astrocytes in culture. J Neurochem 63:2202-2209 (1994).
36. Thompson, TA, Lewis JM, Dejneka S, Severs WB, Polavarapu R, Billingsley ML. Induction of apoptosis by organotin compounds in vitro: neuronal protection in antisense oligonucleotides directed against stannin. J Pharmacol Exp Ther 276:1201-1215 (1996).
37. Maier WE, Bartenbach MJ, Brown HA, Tilson HA, Harry GJ. Induction of tumor necrosis factor alpha in cultured glial cells by trimethyltin. Neurochem Int 30:385-392 (1997).
38. McCarthy KD, de Vellis J. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol 85:890-902 (1980).
39. Koelle GB. The histochemical differentiation of types of cholinesterases and their localizations in tissues of the cat. J Pharmacol Exp Ther 100:158-179 (1950).
40. Henn F, Hamberger A, Glial cell function: uptake of transmitter substances. Proc Natl Acad Sci USA 68:2686-2690 (1971).
41. Schousboe A, Hertz L. Regulation of glutamatergic and GABAergic neuronal activity by astroglial cells. In: Dale's Principle and Communication Between Neurones (Osborne NO, ed). Oxford:Pergamon Press, 1984;113-141.
42. Desmedt JE, LaGrutta G. The effect of selective inhibition of pseudocholinesterase on the spontaneous and evoked activity of the cat's cerebral cortex. J Physiol 136:20-40 (1957).
43. Bowery NG, Brown DA, Collins CGS, Galvan M, Marsh S, Yamani G. Indirect effects of ammo-acids on sympathetic ganglion cells mediated through release of γ-aminobutyric acid from glial cells. Br J Pharmacol 57:73-91 (1976).
44. Schousboe A, Larsson OM, Frandsen A, Belhage B, Pasantes- Morales H, Krogsgaard-Larsen P. Neuromodulatory actions of glutamate, GABA, and taurine: regulatory role of astrocytes. In: Plasticity and Regeneration of the Nervous System (Timeras PS, Privat A, Giacobini E, Lauder J, Vernadakis A, eds). New York:Plenum Press, 1991;165-180.
45. Teichberg VI. Glial glutamate receptors: likely actors in brain signaling. FASEB J 5:3086-3091 (1991).
46. Martinez-Hernandez AM, Bell KP, Norenberg MD. Glutamine synthetase: glial localization in brain. Science 195:1356-1358 (1977).
47. Gammer W. Glutamine synthetase in the central nervous system is not confined to astrocytes. J Neuroimmunol 26:173-178 (1990).
48. Ericinska M, Silver IA. Metabolism and role of glutamate in mammalian brain. Prog Neurobiol 35:245-296 (1990).
49. Flott B, Seifert W. Characterization of glutamate uptake systems in astrocyte primary cultures from rat brain. Glia 4:293-304 (1991)
50. Gallo V, Giovanni C, Suergiu R, Levi G. Expression of excitatory amino acid receptors by cerebellar cells of the type 2 astrocyte cell lineage. J Neurochem 52:1-9 (1989).
51. Kaplan GP, Hartman BK, Creveling CR. Immunohistochemical demonstration of catechol-O-methyltransferase in mammalian brain. Brain Res 167:241-250 (1979).
52. Levitt P, Pintar JE, Breakefield XO. Immunocytochemical demonstration of monoamine oxidase B in brain astrocytes and serotonergic neurons. Proc Natl Acad Sci USA 79:6385-6389 (1962).
53. Westlund KN, Denny RM, Kochersperger LM, Rose RM, Abell CW. Distinct monoamine oxidase A and B populations in primate brain. Science 230:181-183 (1985).
54. Tiffany-Casriglioni E. Cell culture models for lead toxicity in neuronal and glial cells. N euro toxicology 14:367-390 (1993).
55. Tiffany-Castiglioni E, Zmudzki J, Wu JN, Rowles TK. Effects of lead treatment on intracellular iron and copper concentrations in cultured astroglia. Metab Brain Res 2:61-79 (1987).
56. Wu JN, Tiffany-Castiglioni E. Reduction by lead of hydrocortisone-induced glycerolphosphate dehydrogenase activity in cultured rat oligodendroglia. In vitro. Cell Dev Biol 23:765-774 (1987).
57. Gebhart AM, Goldstein GW. Use of in vitro system to study the effects of lead on astrocyte-endothelial interactions: a model for studying toxic injury to the blood-brain barrier. Toxicol Appl Pharmacol 94:191-206 (1988).
58. Choi DW, Rothman SM. The role of glutamate neurotoxicity in hypoxic ischemia neuronal death. Annu Rev Neurosci 13:171-182 (1990).
59. Ray DE. Pesticides derived from plants and other organisms. In: Handbook of Pesticide Toxicology (Hayes WJ, ed). New York-Academic Press, 1991;585-636.
60. Bortenstein JE, Sato G. Cell Culture and the Neurosciences. New York:Plenum Press, 1985.
61. Bruinink A, Reiser P. Ontogeny of MAP2 and GFAP antigens in primary cultures of embryonic chick brain. Effect of substratum, oxygen tension, serum and Ara-C. Int J Dev Neurosci 9(3):269-279 (1991).
62. Smith RA. Primary cultures of adult mammalian sensory neurons and other in vitro systems of use in neurotoxicological studies. Arch Toxicol Suppl 14:8-14 (1991).
63. Smith RA, Jiang Z-G. Neuronal moduation and plasticity in vitro. Int Rev Cytol 153:233-296 (1994).
64. Dawis S, Hofmann H, Niemeyer G. The electroretinogram, standing potential, and light peak of the perfused cat eye during acid-base changes. Vision Res 25:1163-1177 (1985).
65. Schneider T, Zrenner E. The effect of fluphenazine on rodmediated retinal responses. Doc Ophthalmol 65:287-296 (1987).
66. Linnemann D, Lyles JM, Bock E. A developmental study of the biosynthesis of the neural cell adhesion molecule. Dev Neurosci 7:230-238 (1985).
67. Teyler TJ. The brain slice preparation: hippocampus. Brain Res Bull 5:391-403 (1980).
68. Rimvall K, Keller F, Waser PG. Development of cholinergic projections in organotypic cultures of rat septum, hippocampus and cerebellum. Dev Brain Res 19:267-278 (1985).
69. Fountain SB, Teyler TJ. Characterizing neurotoxicity using the in vitro hippocampal brain slice preparation: heavy metals. In: Model Systems in Neurotoxicological approaches to Animal Testing. New York:Alan R. Liss, 1987;19-31.
70. Seeds NW. Differentiation of aggregating brain cell cultures. In: Tissue Culture of the Nervous System (Sato G, ed). New York:Plenum Press, 1973;35-53.
71. Honegger P, Richelson E. Biochemical differentiation of mechanically dissociated mammalian brain in aggregating cell culture. Brain Res 109:335-354 (1976).
72. Honegger P. Biochemical differentiation in serum-free aggregating brain cell cultures. In: Cell Culture in the Neurosciences (Bottenstein JE, Sato G, eds). New York:Plenum Press, 1985;223-243.
73. DeLong GR. Histogenesis of fetal mouse isocortex and hippocampus in reaggregating cell cultures. Dev Biol 22:563-583 (1970).
74. Lu EJ, Brown WJ, Cole R, deVellis J. Ultrastructural differentiation and synaptogenesis in aggregating rotation cultures of rat cerebral cells. J Neurosci Res 5:447-463 (1980).
75. Trapp BD, Honneger P, Richelson E, Webster H deF. Morphological differentiation of mechanically dissociated fetal rat brain in aggregating cell cultures. Brain Res 160:117-180 (1979).
76. Seeds NW, Vatter AE. Synaptogenesis in reaggregating brain cell cultures. Proc Natl Acad Sci USA 68:3219-3222 (1971).
77. Trapp BD, Webster H deF, Johnson D, Quarles RH, Cohen SR, Murray MR. Myelin formation in rotation-mediated aggregating cell cultures: immunocytochemical, electronmicroscopic and biochemical observations. J Neurosci 2:986-993 (1982).
78. Honegger P, Werffeli P. Use of aggregating cell cultures for toxicological studies. Experientia 44:817-823 (1988).
79. Schilter B, Honegger P. Validation of three in vitro toxicity/ teratogenicity test systems using identical coded compounds. I. Aggregating brain cell cultures. Teratology 44:31A (1991).
80. Davenport CJ, Williams DA, Morgan KT. Neurotoxicology using cell culture, CIIT Activities 9:1 (1989).
81. Brockes JP, Fields KL, Raff MC, Studies on cultured rat Schwann cells. I. Establishment of purified populations from cultures of peripheral nerve. Brain Res 165:105-118 (1979).
82. Mason PW, Attema BL, DeVries GH. Isolation and characterization of Schwann cells from frozen sciatic nerves. Transact Am Soc Neurochem 22 (1991)
83. Tennekoon GI, Yoshino J, Peden KWC, Bigbee J, Rutkowski JL, Kishimoto Y, DeVries G, McKhann GM. Transfection of neonatal rat Schwann cells with SV-40 large T antigen gene under control of the metallothionein promoter. J Cell Biol 105:2315-2325 (1987).
84. Yoshino JE, Neuberger TJ, Cornbrooks CJ, Tennekoon GI, Eng LF, DeVries GH. Proliferation and differentiation of a transfected Schwann cell line is altered by an artificial basement membrane. Glia 3:315-321 (1990).
85. 3H-thymidine incorporation by primary cultures of highly purified non- neuronal cells. Brain Res 114:415-426 (1976).
86. Salzer JL, Bunge RP. Studies of Schwann cell proliferation. I: An analysis in tissue culture of proliferation during development, Wallerian degeneration and direct injury. J Cell Biol 84:739-752 (1980).
87. Salzer JL, Williams AK, Glaser L, Bunge RP. Studies of Schwann cell proliferation. II: Characterization of the stimulation and specificity of the response to neurite membrane fraction. J Cell Biol 84:753-766 (1980).
88. Salzer JL, Bunge RP, Glaser L. Studies of Schwann cell proliferation. III: Evidence for the surface localization of the neurite mitogen. J Cell Biol 84:767-778 (1980).
89. DeVries GH, Salzer JL, Bunge RP. Axolemma-enriched fractions isolated from PNS and CNS are mitogenic for cultured Schwann cells. Dev Brain Res 3:295-299 (1982).
90. Yoshino JE, Dinneen MP, Lewis BL, Meador-Woodruff JH, DeVries GH. Differential proliferative responses of cultured Schwann cell to axolemma and myelin-enriched fractions. J Cell Biol 99:2309-2323 (1984).
91. Pleasure D, Kreider B, Shuman S, Sobue G. Tissue culture studies of Schwann cell proliferation and differentiation. Dev Neurosci 7:364-373 (1985).
92. Diamond L, Baird WM. Chemical carcinogenesis in vitro. In: Growth, Nutrition and Metabolism of Cells in Culture, Vol 3 (Rothblat GH, Cristofalo VJ, eds). New York:Academic Press, 1977;421.
93. Sandberg K, Schnaar RL, McKinney M, Fisher A, Coyle JT. AF64A: an active site directed irreversible inhibitor of acetylcholinetransferase. J Neurochem 44:439-445 (1985).
94. Guroff G. PC12 cells as model of neuronal differentiation. In: Cell Culture in the Neurosciences (Bottenstein JE, Sato G, eds). New York:Plenum Publishing, 1985;245-272.
95. Benda P, Lightbody J, Sato G, Levine I, Sweet W. Differentiated rat glial cell strain in tissue culture. Science 161:370-371 (1968).
96. Kanje M, Walum E, Edstrom A. Effects of dibutyryl cyclic AMP and cytochalasin B on cultured human glioma cells. Z Mikrosk Anat Frosch 93:487-496 (1979).
97. Edstrom A, Kanje M, Lofgren P, Walum E. Drug-induced alterations in morphology and level of cAMP in cultured human glioma cells. Exp Cell Res 95:359-364 (1975).
98. Fontana A, Grieder A, Arrenbrecht S, Grob P. In vitro stimulation of glia cells by a lymphocyte-produced factor. J Neurol Sci 46:55-62 (1980).
99. Kumar S, Sachar K, Huber J, Weingarten DP, de Vellis J. Glucocorticoids regulate the transcription of glycerol phosphate dehydrogenase in cultured glial cells. J Biol Chem 260:14743-14747.
100. Ye P, Kanoh M, Zhu W, Laszkiewicz I, Royland JE, Wiggins RC, Konat G. Cyclic AMP-induced upregulation of proteolipid protein and myelin associated glycoprotein gene expression in C6 cells. J Neurosci Res 31:578-583 (1992).
101. Zhu W, Kanoh M, Ye P, Laszkiewicz I, Royland JE, Wiggins RC, Konat G. Retmoic acid-regulated expression of proteolipid protein and myelin-associated glycoprotein genes in C6 glioma cells. J Neurosci Res 31:745-750 (1992).
102. Grubinska B, Laszkiewicz I, Royland J, Wiggins RC, Konat GW. Differentiation-specific demethylation of myelin associated glycoprotein gene in cultured oligodendrocytes. J Neurosci Res 39:233-242 (1994).
103. Erkell LJ, Walum E. Differentiation of cultured neuroblastoma cells by urea derivatives. FEBS Lett 104:401-404 (1970).
104. Carrington CD, Carrington MN, Abou-Donia MB. Neurotoxic esterase in cultured cells: an in vitro alternative for the study of organophosphorus compound-induced delayed neurotoxicity. In: Alternative Methods in Toxicology. Vol 3: In Vitro Toxicology (Goldberg AM, ed). New York:Mary Ann Liebert, 1985;457-465.
105. Fedalei A, Nardone RL. An in vitro alternative for testing the effect of organophosphates on neurotoxic esterase activity. In: Alternative Methods in Toxicology. Vol I: Product Safety Evaluation (Goldberg AM, ed). 1983;252-267.
106. Atterwill CK, Johnston H, Thomas SM. Models for the in vitro assessment of neurotoxicity in the nervous system in relation to xenobiotic and neurotrophic factor-mediated events. Neurotoxicology 13:39-53 (1992).
107. Veronesi B, Enrich M. Differential cytotoxic sensitivity in mouse and human cell lines exposed to organophosphate insecticides. Toxicol Appl Pharmacol 120:240-246 (1993).
108. Greene LA, Tischler AS. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci USA 73:2424-2428 (1976).
109. Fujita K, Lazaroxici P, Guroff G. Regulation of the differentiation of PC12 pheochromocytoma cells. Environ Health Perspect 80:127-142 (1989).
110. Sandberg K, Berry CJ, Rogers TB. Studies on the intoxication pathway of teatanus toxin in the rat pheochromocytoma (PC12) cell line. Binding, internalization, and inhibition of acetylcholine release. J Biol Chem 264:5679-5686 (1989).
111. Seegal RF, Brosch K, Bush B, Ritz M, Shain W. Effects of Arochlor 1254 on dopamine and norepinephrine concentrations in pheochromocytoma (PC-12) cells. Neurotoxicology 10:757-764 (1989).
112. 2+ channels in synaptosomes and pheochromocytoma cells: radiotracer flux and binding studies. Mol Pharmacol 38:102-113 (1990).
113. Shafer TJ, Atchison WD. Methylmercury blocks N- and L-type Ca2+ channels in nerve growth factor-differentiated pheochromocytoma cells. J Pharmacol Exp Ther 258:149-157 (1991).
114. Westergaard N, Sonnewald U, Petersen SB, Schousbe A. Characterization of microcarrier cultures of neurons and astrocytes from cerebral cortex and cerebellum. Neurochem Res 16:919-923 (1991).
115. Hamprech B. Structural, electrophysiological, biochemical, and pharmacological properties of neuroBlastoma-glioma cell hybrids in culture. Int Rev Cytol 49:99-170 (1977).
116. Dahms NM, Schnaar RL. Ganglioside composition is regulated during differentiation in the neuroblasroma X glioma hybrid cell line NB 1-8-115. J Neurosci 3:806-817 (1983).
117. Durham HD, Dahrouge S, Cashman S. Evaluation of the spinal cord neuron X neuroblastoma hybrid cell line NSC-34 as a model for neurotoxicity testing. Neurotoxicology 14:387-396 (1993).
118. Durham HD. 2,5-Hexanedione aggregates vimentin, but not keratin-intermediate filaments of PtK1 cells. Cell Biol Int Rep 11:307-404 (1987).
119. Atterwill CK, Walum E. Neurotoxicity in vitro: model systems and practical applications. Toxicol In Vitro 3:159-161 (1989).
120. Bolon B, Dorman DC, Bonnefoi MS, Randall H, Morgan KT. Histopathologic approaches to chemical toxicity using primary dissociated neural cells grown in chamber slides. Toxicol Pathol 21:465-479 (1993).
121. Takenaka T. Particle movement in axonal transport. In: Axoplasmic Transport (Iqbal Z, ed). Boca Raton, FL:CRC Press, 1886;109-118.
122. Walum E, Ekblad-Sekund G, Nyberg E, Gustafsson L. Cultured neuroblastoma cells as neurotoxicological models: acrylamide induced neurite disintegration. In: Model Systems in Neurotoxicology: Alternative Approaches to Animal Testing (Shahar A, Goldberg AM, eds). New York:Alan R. Liss, 1987;121-136.
123. Garnass KR, Windebank AJ, Blexrud MD, Kurtz SB. Ultras true rural changes produced in dorsal root ganglia in vitro by exposure to erhylene oxide from hemodialyzers. J Neuropathol Exp Neurol 50:256-262 (1991).
124. Monnet-Tschudi F, Zurich MG, Pithon E, van-Melle G, Honegger P. Microglial responsiveness as a sensitive marker for trimethyltin (TMT) neurotoxicity. Brain Res 690:8-14 (1995).
125. Campenot RB. Local control of neurite development by nerve growth factor. Proc Natl Acad Sci USA 74:4516-4519 (1977).
126. Luckenbill-Edds L, Van Horn C, Greene LA. Fine structure of initial outgrowth of processes induced in a pheochromocytoma cell line (PC12) by nerve growth factor. J Neurocytol 8:493-511 (1979).
127. Quarles RH, Morell P, McFarlin DE. Diseases involving myelin. In: Basic Neurochemistry, 5th ed (Siegel GJ, Agranoff BW, Albers RW, Molinoff PB, eds). New York:Raven Press, 1994;771-792.
128. Morell P, Myelin. New York:Plenum Press, 1984.
129. Webster HF. Development of peripheral myelinated and unmyelinated nerve fibers. In: Peripheral Neuropathology Vol 1 (Dyck PJ, Thomas PK, Lambert EH, eds). Philadelphia: WB Saunders, 1975;37-61.
130. Wood JG, Engel EL. Peripheral nerve glycoproteins and myelin fine structure during development of the rat sciatic nerve. J Neurocytol 5:605-615 (1976).
131. Willison HJ, Ilyas AI, O'Shannessy DJ, Pulley MJ, Trapp BD, Quarles RH. Myelin associated glycoprotein and related glycoconjugates in developing cat peripheral nerve: a correlative biochemical and morphometric study. J Neurochem 49:1853-1862 (1987).
132. Notterpek LM, Bullock PN, Maled-Hedayat S, Fisher R, Rome LH. Myelination in cerebellar slice cultures: development of a system amenable to biochemical analysis. J Neurosci Res 36:621-634 (1993).
133. Towfighi J. Hexachlorophene, In: Experimental and Clinical Neurotoxicology (Spencer PS, Schaumburg HH, eds). Baltimore:Williams & Wilkins, 1980;440-455
134. Krigman MR, Bouldin TW, Mushak P. Lead. In: Experimental and Clinical Neurotoxicology (Spencer PS, Schaumburg HH, eds). Baltimore:Williams & Wilkins, 1980;490-507.
135. Cammer W. Toxic demyelination: biochemical studies and hypothetical mechanisms. In: Experimental and Clinical Neurotoxicology (Spencer PS, Schaumburg HH, eds). Bahimore:Williams & Wilkins, 1980;92-99.
136. Spencer PS, Schaumburg HH. Classification of neurotoxic disease: a morphological approach. In: Experimental and Clinical Neurotoxicology (Spencer PS, Schaumburg HH, eds). Baltimore:Williams & Wilkins, 1980;92-99.
137. Pleasure DE. Biochemistry of neuropathy. In: Basic Neurochemistry, 5th ed (Siegel GJ, Agranoff BW, Albers RW, Molinoff PB, eds). New York:Raven Press, 1994;761-770.
138. Royland JE, Konar GW, Wiggins RC. Myelin gene activation; a glucose sensitive critical period in development. J Neurosci Res 36:399-404 (1993).
139. Matthieu JM, Honegger P, Farrod P, Gautier E, Dolivo M. Biochemical characterization of a myelin fraction isolated from rat brain aggregating cell cultures. J Neurochem 32:869-881 (1979).
140. Matthieu JM, Comte V, Tosic M, Honegger P. Myelin gene expression during demyelination and remyelination in aggregating brain cell cultures. J Neuroimmunol 40:231-234 (1992).
141. Zurich MG, Matthieu JM, Honegger P. Improvement of culture conditions for aggregating brain cells to study remyelination. Schweiz Arch Neurol Psychiatr 144:228-232 (1993).
142. Goodrum JF, and Morell P. Axonal transport. In: Neurotoxicology (Abou-Donia MB, ed). Boca Raton, FL:CRC Press, 1992;79-120.
143. Brat DJ, Brimijoin S. A paradigm for examing toxicant effects on variability, structure, and axonal transport of neurons in culture. Mol Neurobiol 6:125-136 (1992).
144. Brat DJ, Brimijoin S. Acrylamide and glycidamide impair neurite outgrowth in differentiating NIE 115 neuroblastoma without disturbing rapid bidirectional transport of organelles observed by video microscopy. J Neurochem 60:2145-2152 (1993).
145. Brat DJ, Windebank AJ, Brimijoin S, Emulsifier for intravenous cyclosporin inhibits neurite outgrowth, causes deficits in rapid axonal transport, and leads to structural abnormalities in differentiating NIE 115 neuroblastoma. J Pharmacol Exp Ther 261:803-810 (1992).
146. Harry GJ, Morell P, Bouldin TW. Acrylamide exposure preferentially impairs axonal transported glycoproteins in myelinated axons. J Neurosci Res 31:554-560 (1992).
147. Walum E, Peterson A. On the application of cultured neuroblastoma cells in chemical toxicity screening. J Toxicol Environ Health 13:511-520 (1984).
148. Bradbury MWB, Lightman SL. The blood brain interface. Eye 4:249-254(1990).
149. Joo F. The blood brain barrier in vitro: ten years of research on microvessels isolated from brain. Neurochem Int 7:1-25 (1985).
150. Orlowski M, Sessa G, Green JP. γ-Glutymyl transpeptidase in brain capillaries: possible site of a blood brain barrier for amino acids. Science 184:66-68 (1974).
151. Vorbrodt AW. Ultrastructural cytochemistry of blood brain barrier endothelia. Prog Histochem Cytochem 3:1-99 (1988).
152. Vannucci SJ. Developmental expression of GLUT1 and GLUT3 glucose transporter in rat brain. J Neurochem 62:1-5 (1994).
153. DeBault LE, Cancilla PA. Induction of γ-glutamyl transpeptidase in isolated cerebral endothelial cells. Adv Exp Med Biol 131:79-88 (1980).
154. Janzer RC, Raff MC. Astrocytes induce blood brain barrier properties in endothelial cells. Nature (London) 325:253-257 (1987).
155. Tontsch U, Bauer HC. Glial cells and neurons induce blood brain barrier related enzymes in cultured cerebral endothelial cells. Brain Res 539:247-253 (1991).
156. Walum E, Hansson E, Harvey AL. In vitro testing of neurotoxicity. ATLA 18:153-179 (1990).
157. Sellstrom A, Algers G, Karlsson B. Somanintoxication and the blood brain barrier. Fundam Appl Toxicol 5:S122-S126 (1985).
158. 14C) sucrose. Brain Res 377:286-291 (1986).
159. Brooks N, Kristt DA. Inhibition of amino acid transport and protein synthesis by mercury chloride and methylmercury in astrocytes: selectivity and reversibility. J Neurochem 53:1228-1237 (1989).
160. Ashani Y, Caftravas GN. Seizure-induced changes in the permeability of the blood-brain barrier following administration of anticholinesterase drugs to rats. Biochem Pharmacol 30(18):2593-2601 (1981).
161. Aschner M, and Aschner JL. Mercury neurotoxicity: mechanisms of blood-barin barrier transport, Neurosci Biobehav Rev 14:169-176 (1990).
162. Bressler JP, Goldstein. Mechanisms of lead neurotoxicity. Biochem Pharmacol 41:479-484 (1991).
163. Stanness KA, Guatteo E, Janigro D. A dynamic model of the blood-brain barrier "in vitro." Neurotoxicology 17:481-496 (1996).
164. Farber JL. The role of calcium in lethal cell injury. Chem Res Toxicol 3:503-508 (1990).
165. 2+-homeostasis. Prog Neurobiol 37:255-285 (1991).
166. Choi DW. Glutamate neurotoxicity in cortical cell culture is calcium dependent. Neurosci Lett 58:293-297 (1985).
167. Nicotera P, Bellomo G, Orrenium S. Calcium-mediated mechanisms in chemically induced cell death. Annu Rev Pharmacol Toxicol 32:449-470 (1992).
168. 2+-dependent processes as mediators of neurotoxicity. Neurotoxicology 13:139-148 (1992).
169. Zimmerman U-JP, Schlaepfer WW. Characterization of a brain calcium-activated protease that degrades neurofilament proteins. Biochemistry 21:3977-3983 (1982).
170. 3H-dopamine from rat striatal synaptosomes: correlation with calcium entry. J Neurosci 3:703-713 (1983).
171. Browning MD, Huganir R, Greengard P. Protein phosphorylation and neuronal function. J Neurochem 45:11-23 (1985).
172. Komulainen H, Bondy SC. Modulation of levels of free calcium within synaptosomes by organochlorine insecticides. J Pharmacol Exp Ther 241:575-581 (1987).
173. 2+ by neurotoxic organometals: distinctive mechanisms. Toxicol Appl Pharmacol 88:77-86 (1987).
174. 2+ by toxic agents; an index of potential neurotoxicity? Trends Pharmacol Sci 9:154-156 (1988).
175. Verity MA, Sarafian TS, Guerra W, Ettinger A, Sharp J. Ionic modulation of triethyl lead neurotoxicity in cerebellar granule cell culture. Neurotoxicology 11:415-426 (1990).
176. Johnson JD, Conroy WG, Isom GE. Alteration of cytosolic calcium levels in PC12 cells by potassium cyanide. Toxicol Appl Pharmacol 88:217-224 (1987).
177. Doherry JD, Nishimura K, Kurihara N, Fujita T. Promotion of norepinephrine release and inhibition of calcium uptake by pyrethroids in rat brain synaptosomes. Pesticide Biochem Physiol 29:187-196 (1987).
178. Kodavanti PRS, Mundy WR, Tilson HA, Harry GJ. Effects of selected neuroactive chemicals on calcium transporting systems in rat cerebellum and on survival of cerebellar granule cells. Fundam Appl Toxicol 21:308-316 (1993).
179. Kodavanti PRS, Dae-Sup Shin, Tilson HA, Harry GJ. Comparative effects of two polychlorinated biphenyl congeners on calcium homeostasis in rat cerebellar granule cells. Toxicol Appl Pharmacol 123:97-106 (1993).
180. Koenig ML, Jope RS. Aluminum inhibits the fast phase of voltage-dependent calcium influx into synaptosomes. J Neurochem 49:316-320 (1987).
181. 2+ mobilization FEBS Lett 267:301-304 (1990).
182. Anghileri LJ. Effects of complexed iron and aluminum on brain calcium. Neurotoxicology 13:475-478 (1992).
183. Bottenstein JE. Differentiated properties of neuronal cell lines. In: Functionally Differentiated Cell Lines (Sato G, ed). New York:Alan R. Liss, 1981; 154-184.
184. Schubert D, Carlisle Ws Look C. Putative neurotransmitters in clonal cell lines. Nature 254:341-343 (1975).
185. Kimes B, Tarikas H, Schubert D. Neuro transmitter synthesis by two clonal nerve cell lines: changes with culture growth and morphological differentiation. Brain Res 79:291-295 (1974).
186. Greene I, Rein G. Synthesis, storage, and release of acetylcholine by noradrenergic pheochromocytoma cell line. Nature 268:349-351 (1977).
187. Reichardt LF, Patterson PH. Neurotransmitter synthesis and uptake by isolated sympathetic neurones in microcultures. Nature 270:147-151 (1977).
188. Johnson MI, ROSS CD, Meyers M, Spitznagel EL, Bunge RP. Morphological and biochemical studies in the development of cholinergic properties in cultured sympathetic neurons. I: Correlative changes in choline acetyltransferase and synaptic vesicle cytochemistry. J Cell Biol 84:680-691 (1980).
189. Furshpan EJ, Potter DD, Landis SC. On the transmitter repertoire of sympathetic neurons in culture. Harvey Lect 76:149-191 (1981).
190. Higgins D, Lacovitti L, Joh TH, Burton H. The immunocytochemical localization of ryrosine hydroxylase within rat sympathetic neurons that release acetylcholine in culture. J Neurosci 1:126-131 (1981).
191. Heifi F, Hartikka J, Eckerstein F, Gnahn H, Heumann R, Schwab M. Nerve growth factor (NGF) increases choline acetyltransferase but not survival or fiber growth of cultured septal cholinergic neurons. Neuroscience 14:55-68 (1985).
192. Bunge R, Johnson M, Ross CD. Nature and nurture in development of the autonomic neuron. Science 199:1409-1416 (1978).
193. Bray D. Surface movements during growth of single explanted neurons. Proc Natl Acad Sci USA 65:905-910 (1970).
194. Chiappinelli V, Giacobini E, Pilar G, Uchimura H. Induction of cholinergic enzymes in chick ciliary ganglion and iris muscle cells during synapse formation. J Physiol 257:749-766 (1976).
195. Giacobini E, Pilar G, Suszkiw J, Uchimura H. Normal distribution and denervation changes of neurotransmitter related enzymes in cholinergic neurons. J Physiol 286:233-253 (1979).
196. Giacobini E. Aging of autonomie synapses. In: Advances in Cellular Neurobiology (Fedoroff S, Herz L, eds). New York:Academic Press, 1982; 173-214.
197. Konig N, Wilkie MB, Lauder J. Dissection of monoaminergic neuronal groups from embryonic rat brain. In: A Dissection and Tissue Culture Manual of the
198. Whitaker-Azmitia PM, Azmitia EC. A tissue culture model of serotonin neurons for studying normal development and screening for drug teratogenicity. In: Alternative Methods in Toxicology and the Life Sciences. Vol 11 : The World Congress on Alternatives and Animal Use in the Life Sciences: Education, Research, Testing (Goldberg A, van Zutphen LFM, eds). New York:Mary Ann Liebert, 1994;141-144.
199. Weissman AD, Johnson JE Jr. Assessing pyschoactive drug neurotoxiciry in vitro: initial studies using NG108-15 neuroblastoma-glioma cells. In: In Vitro Toxicology: Mechanisms and New Technology. Vol 11: Alternatives Methods In Toxicology (Goldberg AM, ed). New York:Mary Ann Liebert, 1992; 125-132.
200. Simerly RB, Swanson LW. The organization of neural inputs to the medial preoptic nucleus of the rat. J Comp Neurol 246:312-342 (1986).
201. Drewe JA, Childs GV, Kunze DL. Synaptic transmission between dissociated adult mammalian neurons and attached synaptic boutons. Science 241:1810-1813 (1988).
202. Bignami A, Dahl D, Rueger DC. Glial fibrillary acidic proteins in normal cells and in pathological conditions. Adv Cell Neurobiol 1:285-309 (1980).
203. Cookson MR, Pentreath VW. Alterations in the glial fibrillary acid protein content of primary astrocyte cultures for evaluation of glial cell toxicity. Toxicol In Vitro 8:351-359 (1994).
204. Cookson MR, Mead C, Austwick SM, Pentreath MW. Use of the MTT assay for estimating toxicity in primary astrocyte and C6 glioma cell cultures. Toxicol In Vitro 9:39-48 (1995).
205. Romero IA, Lister T, Richards MK, Sevillel MP, Wylie SP, Ray DE. Early metabolic changes during m-nitrobenzene neurotoxicity and the possible role of oxidative stress. Free Radic Biol Med 18:311-319 (1995).
206. Goldberg AM. An approach to the development of in vitro toxicological methods. Food Chem Toxicol 23:205-208 (1985).
207. Goldberg AM, ed. Alternataive Methods in Toxicology, in Vitro Toxicology Approaches to Validation, Vol 5. New York:Mary Ann Liebert, 1987.
208. Goldberg AM. Alternative Methods in Toxicology, Progress in in Vitro Toxicology, Vol 6. New York:Mary Ann Liebert, 1989.
209. Goldberg AM, Brookes N, Burt DR. The use of spinal cord cell cultures in the study of neurotoxicological agents. Toxicology 17:233-235 (1980).
210. Scala RA. Theoretical approaches to validation. In: In Vitro Toxicology Approaches to Validation. Alternative Methods in Toxicology, Vol 5 (Goldberg AM, ed). New York:Mary Ann Liebert, 1987;1-10.
211. Veronesi B. The use of cell culture for evaluating neurotoxicity. In: Neurotoxicology (Tilson H, Mitchell C, eds). New York:Raven Press, 1992;21-49.
212. Williams SP, Davenport-Jones J, Egan C, O'Hare S, Cookson M, McLean R, Garle MJ, Pentreath V, Atterwill CK. Phase I of an in vitro neurotoxicological prevalidation trial. Toxicol In Vitro 8:799-802 (1994).